Difference between revisions of "Hepatitis B"

From Libre Pathology
Jump to navigation Jump to search
Line 4: Line 4:
*May lead to [[hepatocellular carcinoma]] without [[cirrhosis]].
*May lead to [[hepatocellular carcinoma]] without [[cirrhosis]].
*High prevalence.
*High prevalence.
*Diagnosis is by serology.
*Diagnosis is by serology - details of serologic testing are in the ''[[Medical_liver_disease#Hepatitis_B|medical liver disease article]]''.
*A vaccination is available and done routinely in a many jurisdictions.<ref>{{Cite journal  | last1 = Leuridan | first1 = E. | last2 = Van Damme | first2 = P. | title = Hepatitis B and the need for a booster dose. | journal = Clin Infect Dis | volume = 53 | issue = 1 | pages = 68-75 | month = Jul | year = 2011 | doi = 10.1093/cid/cir270 | PMID = 21653306 }}</ref>  
*A vaccination is available and done routinely in a many jurisdictions.<ref>{{Cite journal  | last1 = Leuridan | first1 = E. | last2 = Van Damme | first2 = P. | title = Hepatitis B and the need for a booster dose. | journal = Clin Infect Dis | volume = 53 | issue = 1 | pages = 68-75 | month = Jul | year = 2011 | doi = 10.1093/cid/cir270 | PMID = 21653306 }}</ref>  



Revision as of 17:42, 25 June 2016

Hepatitis B is a relatively common medical liver disease caused by the hepatitis B virus.

General

Associated pathology:

Microscopic

Features:

  • Lobular inflammation - this is non-specific finding.
    • Hepatocyte necrosis:
      • Necrotic hepatocytes look a lot like neutrophils - however:
        • Cytoplasm is more pink.
        • Round apoptotic bodies.
  • Ground glass hepatocytes - important.

DDx:

Image

IHC

  • Hepatitis B +ve.

See also

References

  1. Leuridan, E.; Van Damme, P. (Jul 2011). "Hepatitis B and the need for a booster dose.". Clin Infect Dis 53 (1): 68-75. doi:10.1093/cid/cir270. PMID 21653306.